ArticleiScience2023

BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine.

Dilhan J Perera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.